Trial NCT05069935

View at ClinicalTrials.gov 
Org. Study IDs: FT538-102

Last trial update was posted on 2023-09-21

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Cyclophosphamide Fludarabine Immunoglobulins

MeSH Conditions

Neoplasms

Other Conditions

Solid Tumor, Adult

Stopping Reasons

This study was terminated by the Sponsor.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID